Fiduciary Alliance’s Biohaven BHVN Stock Holding History

Fiduciary Alliance’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17	Closed	-$407	–	245
2023 Q2	$407	Buy	+17	New	+$293	﹤0.01%	935
2023 Q1	–	Sell	-17	Closed	-$236	–	219
2022 Q4	$236	Buy	+17	New	+$240	﹤0.01%	894

Other funds holding BHVN

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Fiduciary Alliance's BHVN Position: Q3 2023 in Review

Fiduciary Alliance sold out of Biohaven (BHVN) in Q3 2023, closing a stake of 17 shares — an estimated $407 sold.

Fiduciary Alliance first reported a position in BHVN in Q4 2022 and held it in 2 quarters. The position peaked at $407 in Q2 2023. 187 funds tracked by Wall St. Rank hold BHVN as of Q3 2023.

Fiduciary Alliance reported no remaining Biohaven position as of Q3 2023 after selling out during the quarter.
Fiduciary Alliance sold 17 Biohaven shares in Q3 2023, an estimated $407.
Fiduciary Alliance first reported a position in Biohaven in Q4 2022 and held it in 2 quarters.
Fiduciary Alliance's Biohaven position peaked at $407 in Q2 2023.
187 funds tracked by Wall St. Rank held Biohaven as of Q3 2023.

Based on Fiduciary Alliance's 13F filing for Q3 2023, filed 18 Oct 2023.